Tevogen, Inc. (TVGN)
7.30
-0.06
(-0.82%)
USD |
NASDAQ |
Sep 14, 10:13
Tevogen Total Liabilities (Quarterly) : 13.62M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 13.62M |
| March 31, 2026 | 14.76M |
| December 31, 2025 | 12.62M |
| September 30, 2025 | 12.32M |
| June 30, 2025 | 13.75M |
| March 31, 2025 | 11.79M |
| December 31, 2024 | 10.14M |
| September 30, 2024 | 10.48M |
| June 30, 2024 | 10.94M |
| March 31, 2024 | 9.166M |
| December 31, 2023 | 99.93M |
| Date | Value |
|---|---|
| September 30, 2023 | 16.56M |
| June 30, 2023 | 16.25M |
| March 31, 2023 | 15.43M |
| December 31, 2022 | 15.06M |
| September 30, 2022 | 15.08M |
| June 30, 2022 | 15.13M |
| March 31, 2022 | 15.18M |
| December 31, 2021 | 15.18M |
| September 30, 2021 | 0.1532M |
| June 30, 2021 | 0.1332M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
| Sarepta Therapeutics, Inc. | 1.661B |
| Anixa Biosciences, Inc. | 1.873M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.728M |
| Shareholders Equity (Quarterly) | -8.889M |
| Debt to Equity Ratio | -1.062 |
| Current Ratio | 0.3267 |
| Net Debt Paydown Yield | -3.84% |